“…Additional evidence on stigma reduction was included in relation to COVID-19 (American Psychological Association, 2020 ; Asmundson and Taylor, 2020 ; Centres for Disease Control and Prevention, 2020 ; Devakumar et al ., 2020 ; Earnshaw, 2020 ; IASC Inter-Agency Standing Committee, 2020 ; Lin 2020 ; Logie and Turan, 2020 ; Nature, 2020 ; World Health Organization, 2020a , 2020b ), SARS (Person et al ., 2004 ), influenza (Barrett and Brown, 2008 ; Earnshaw and Quinn, 2013 ), Ebola (Davtyan et al ., 2014 ; IASC Reference Group on Mental Health and Psychosocial Support, 2015 ; Mayrhuber et al ., 2017 ), tuberculosis (Chang and Cataldo, 2014 ), leprosy (Topp et al ., 2019 ), HIV/AIDS (Mak et al ., 2017 ; Hartog et al ., 2020 ), mental illness (Thornicroft et al ., 2016 ; Janoušková et al ., 2017 ; Nyblade et al ., 2019 ) and mixed conditions (Mak et al ., 2006 , 2009 ; Fischer et al ., 2019 ; Rao et al ., 2019 ; World Health Organization, 2019 ). These additional materials represented a mixture of editorials, commentaries, opinion pieces, correspondence and narrative reports; technical guidance, or briefing papers/reports; data-based studies reporting on stigma experiences; systematic reviews (that were not selected as key evidence for this review, or that did not meet criteria for inclusion as evidence); and one scoping review.…”